No. | Document Title | ID | Updated | Views |
---|---|---|---|---|
261 | Disease Site | 101823 | 2022-12-02 | 278 |
262 | Level | 101821 | 2022-12-02 | 200 |
263 | Device | 101820 | 2022-12-02 | 196 |
264 | Drugs | 101819 | 2022-12-02 | 186 |
265 | Modalities | 101818 | 2022-12-02 | 213 |
266 | Arm Description | 101817 | 2022-12-02 | 216 |
267 | Arm Code | 101816 | 2022-12-02 | 206 |
268 | Arm | 101815 | 2022-12-02 | 279 |
269 | Step Type | 101814 | 2022-12-02 | 195 |
270 | Step | 101813 | 2022-12-02 | 183 |
271 | Exempt (if applicable) | 101811 | 2022-12-02 | 186 |
272 | Expanded Access Status | 101810 | 2022-12-02 | 183 |
273 | Expanded Access | 101809 | 2022-12-02 | 178 |
274 | IND/IDE: Expiration Date | 101807 | 2022-12-02 | 198 |
275 | FDA Approval Date | 101806 | 2022-12-02 | 210 |
276 | IND/IDE Submit Date | 101805 | 2022-12-02 | 178 |
277 | Grantor | 101804 | 2022-12-02 | 169 |
278 | NCI/NIH Institution | 101803 | 2022-12-02 | 176 |
279 | Investigational Drug/Device | 101800 | 2022-12-02 | 177 |
280 | Fund Account No. | 101797 | 2022-11-29 | 236 |
Not finding what you are looking for? Suggest a new document be created.